CN1031323A - 避孕植入剂 - Google Patents
避孕植入剂 Download PDFInfo
- Publication number
- CN1031323A CN1031323A CN88104894A CN88104894A CN1031323A CN 1031323 A CN1031323 A CN 1031323A CN 88104894 A CN88104894 A CN 88104894A CN 88104894 A CN88104894 A CN 88104894A CN 1031323 A CN1031323 A CN 1031323A
- Authority
- CN
- China
- Prior art keywords
- implant
- core material
- weight
- vinyl acetate
- eva
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Nanotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
- Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (5)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL8701868 | 1987-08-08 | ||
NL8701868 | 1987-08-08 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1031323A true CN1031323A (zh) | 1989-03-01 |
CN1024753C CN1024753C (zh) | 1994-06-01 |
Family
ID=19850428
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN88104894A Expired - Lifetime CN1024753C (zh) | 1987-08-08 | 1988-08-06 | 避孕植入剂的制造方法 |
Country Status (19)
Country | Link |
---|---|
US (3) | US4957119A (zh) |
EP (1) | EP0303306B1 (zh) |
JP (1) | JP2571831B2 (zh) |
KR (1) | KR950008763B1 (zh) |
CN (1) | CN1024753C (zh) |
AT (1) | ATE86484T1 (zh) |
AU (1) | AU603475B2 (zh) |
CA (1) | CA1309949C (zh) |
DE (2) | DE3879031T2 (zh) |
DK (1) | DK173166B1 (zh) |
ES (1) | ES2054784T3 (zh) |
FI (1) | FI93421C (zh) |
HK (1) | HK1002020A1 (zh) |
IE (1) | IE61730B1 (zh) |
MX (1) | MX9203817A (zh) |
NL (1) | NL980027I2 (zh) |
NZ (1) | NZ225399A (zh) |
PT (1) | PT88220B (zh) |
ZA (1) | ZA885034B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1088993C (zh) * | 1996-10-11 | 2002-08-14 | 上海市计划生育科学研究所 | 含孕二烯酮的长效皮下避孕埋植剂 |
CN101130057B (zh) * | 2007-07-06 | 2011-04-27 | 复旦大学 | 胸腺五肽长效植入剂及其制备方法 |
CN101209238B (zh) * | 2006-12-27 | 2012-05-09 | 辽宁省计划生育科学研究院 | 含孕二烯酮的生物降解型长效皮下避孕埋植剂及其制备 |
CN113209050A (zh) * | 2021-05-14 | 2021-08-06 | 浙江恒冀制药有限责任公司 | 基于生物相容性聚合物的长效体内皮埋或内植缓释制剂 |
Families Citing this family (91)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5114719A (en) * | 1987-04-29 | 1992-05-19 | Sabel Bernhard A | Extended drug delivery of small, water-soluble molecules |
US5156164A (en) * | 1988-10-13 | 1992-10-20 | Leveen Harry H | Iodine contraceptive sponge |
BE1002600A3 (fr) * | 1988-11-23 | 1991-04-09 | Wildemeersch Dirk | Dispositif intra-uterin perfectionne. |
IE71202B1 (en) * | 1990-12-17 | 1997-02-12 | Akzo Nv | Progestagen-only contraceptive |
WO1993017662A1 (en) * | 1992-03-02 | 1993-09-16 | Daratech Pty. Ltd. | Improved implants |
ES2150427T3 (es) * | 1992-06-02 | 2000-12-01 | Bard Inc C R | Procedimiento y dispositivo de implante para el suministro de farmacos a largo plazo. |
US5368588A (en) * | 1993-02-26 | 1994-11-29 | Bettinger; David S. | Parenteral fluid medication reservoir pump |
US5443461A (en) * | 1993-08-31 | 1995-08-22 | Alza Corporation | Segmented device for simultaneous delivery of multiple beneficial agents |
US5681817A (en) | 1994-02-04 | 1997-10-28 | The Medical College Of Hampton Roads | Treatment of ovarian estrogen dependent conditions |
US5660848A (en) * | 1994-11-02 | 1997-08-26 | The Population Council, Center For Biomedical Research | Subdermally implantable device |
US5521166A (en) * | 1994-12-19 | 1996-05-28 | Ortho Pharmaceitical Corporation | Antiprogestin cyclophasic hormonal regimen |
DE19539361A1 (de) * | 1995-10-23 | 1997-04-24 | Basf Ag | Verfahren zur Herstellung von mehrschichtigen, festen Arzneiformen zur oralen oder rektalen Verabreichung |
US5733565A (en) * | 1996-02-23 | 1998-03-31 | The Population Council, Center For Biomedical Research | Male contraceptive implant |
US6203813B1 (en) | 1997-01-13 | 2001-03-20 | Lance L. Gooberman | Pharmaceutical delivery device and method of preparation therefor |
TW358031B (en) * | 1997-04-11 | 1999-05-11 | Akze Nobel N V | Drug delivery system for 2 or more active substances |
DE19744135C1 (de) * | 1997-09-29 | 1999-03-25 | Schering Ag | Beschichtete medizinische Implantate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Restenoseprophylaxe |
CA2331132C (en) | 1998-05-01 | 2008-12-16 | Fei Enterprises, Ltd. | Method for injection molding manufacture of controlled release devices |
US6117441A (en) * | 1998-07-02 | 2000-09-12 | The Population Council, Inc. | Silicone core long term androgen delivery implant |
AU4957999A (en) * | 1998-07-17 | 2000-02-07 | Pharmacia & Upjohn Company | Subcutaneous medroxyprogesterone acetate for contraception |
US6063395A (en) * | 1998-11-12 | 2000-05-16 | Leiras Oy | Drug delivery device especially for the delivery of progestins and estrogens |
US6117442A (en) * | 1998-11-12 | 2000-09-12 | Leiras Oy | Drug delivery device, especially for the delivery of androgens |
US6217895B1 (en) | 1999-03-22 | 2001-04-17 | Control Delivery Systems | Method for treating and/or preventing retinal diseases with sustained release corticosteroids |
CA2267743C (en) * | 1999-03-30 | 2011-07-26 | Robert F. Casper | Low dose estrogen interrupted hormone replacement therapy |
US6375972B1 (en) | 2000-04-26 | 2002-04-23 | Control Delivery Systems, Inc. | Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
IL153648A0 (en) * | 2000-08-23 | 2003-07-06 | Akzo Nobel Nv | Novel testosterone ester formulation for human use |
US7776310B2 (en) | 2000-11-16 | 2010-08-17 | Microspherix Llc | Flexible and/or elastic brachytherapy seed or strand |
WO2002092054A2 (en) * | 2001-05-11 | 2002-11-21 | Ortho-Mcneil Pharmaceutical, Inc. | Immune modulation device for use in animals |
HUP0400390A2 (hu) | 2001-07-02 | 2004-09-28 | Akzo Nobel N.V. | Tetrahidrokinolin-származékok és ezeket tartalmazó gyógyszerkészítmények |
KR20040036928A (ko) * | 2001-08-31 | 2004-05-03 | 쉐링 오와이 | 약물 전달 시스템 |
TWI228508B (en) | 2001-09-04 | 2005-03-01 | Akzo Nobel Nv | Thieno[2,3-d]pyrimidines with combined LH and FSH agonistic activity |
NZ531375A (en) | 2001-09-04 | 2005-06-24 | Akzo Nobel Nv | Glycine-substituted thieno [2,3-d]pyrimidines with combined LH and FSH agonistic activity may be used to treat fertility disorders |
BR0307218A (pt) * | 2002-01-24 | 2004-12-07 | Smart Drug Systems Inc | Composição farmacêutica com liberação prolongada |
CN1652799A (zh) * | 2002-03-11 | 2005-08-10 | 詹森药业有限公司 | 只用抑制硫酸酯酶的孕激素的避孕给药方案 |
TWI297685B (en) | 2002-04-04 | 2008-06-11 | Organon Nv | Non-steroidal progesterone receptor modulators |
US8871241B2 (en) * | 2002-05-07 | 2014-10-28 | Psivida Us, Inc. | Injectable sustained release delivery devices |
AU2003234439A1 (en) * | 2002-05-07 | 2003-11-11 | Control Delivery Systems, Inc. | Processes for forming a drug delivery device |
PT2561860T (pt) * | 2002-05-31 | 2018-05-08 | Titan Pharmaceuticals Inc | Dispositivo polimérico implantável para a libertação prolongada de buprenorfina |
ES2277139T3 (es) * | 2002-08-28 | 2007-07-01 | Robert Casper | Regimen de reposicion de estrogenos. |
KR20050072812A (ko) | 2002-11-07 | 2005-07-12 | 악조 노벨 엔.브이. | 안드로겐-수용체와 관련된 질병의 치료에 효과적인 인돌 |
TWI322012B (en) | 2002-12-20 | 2010-03-21 | Organon Nv | Tetrahydroquinoline derivatives |
TWI306855B (en) | 2002-12-20 | 2009-03-01 | Organon Nv | Tetrahydroquinoline derivatives |
EP1610791B1 (en) * | 2003-03-31 | 2011-02-23 | Titan Pharmaceuticals, Inc. | Implantable polymeric device for sustained release of dopamine agonist |
DE602004026173D1 (de) | 2003-04-29 | 2010-05-06 | Gen Hospital Corp | Verfahren und vorrichtungen für die verzögerte freisetzung von mehreren arzneimitteln |
TWI336627B (en) | 2003-05-23 | 2011-02-01 | Organon Nv | Drug delivery system,and use and manufacturing method thereof |
MXPA05012768A (es) * | 2003-05-30 | 2006-02-22 | Titan Pharmaceuticals Inc | Dispositivo polimerico implantable para liberacion prolongada de nalmefeno. |
AU2004249295A1 (en) * | 2003-06-20 | 2004-12-29 | Viral Genomix, Inc. | Compositions for and methods for treating HIV |
US7976847B2 (en) * | 2004-01-13 | 2011-07-12 | Vasogenix Pharmaceuticals, Inc. | Controlled release CGRP delivery composition for cardiovascular and renal indications |
WO2005070445A2 (en) * | 2004-01-13 | 2005-08-04 | Vasogenix Pharmaceuticals, Inc. | Methods for treating acute myocardial infarction by calcitonin gene related peptide and compositions containing the same |
CA2552757A1 (en) * | 2004-01-13 | 2005-08-04 | Vasogenix Pharmaceuticals, Inc. | Methods of using cgrp for cardiovascular and renal indications |
TWI434676B (zh) | 2004-03-19 | 2014-04-21 | Merck Sharp & Dohme | 可用x射線看出之藥物遞送裝置 |
TW200531977A (en) | 2004-03-25 | 2005-10-01 | Akzo Nobel Nv | Progesterone receptor modulators |
TW200602317A (en) | 2004-04-23 | 2006-01-16 | Akzo Nobel Nv | Novel androgens |
DK1629844T4 (da) | 2004-07-13 | 2012-05-29 | Bayer Schering Pharma Oy | Retarderet indgivelsessystem med kontrolleret initialudbrud |
WO2006078320A2 (en) | 2004-08-04 | 2006-07-27 | Brookwood Pharmaceuticals, Inc. | Methods for manufacturing delivery devices and devices thereof |
US11246913B2 (en) | 2005-02-03 | 2022-02-15 | Intarcia Therapeutics, Inc. | Suspension formulation comprising an insulinotropic peptide |
AU2006259368A1 (en) | 2005-06-15 | 2006-12-28 | Hydra Biosciences, Inc. | Modulators of sperm hypermotility and uses thereof |
EP1743638A1 (en) | 2005-07-15 | 2007-01-17 | Laboratorios Del Dr. Esteve, S.A. | Pharmaceutical formulations of substituted pyrazoline compounds |
US7682356B2 (en) | 2006-08-09 | 2010-03-23 | Intarcia Therapeutics, Inc. | Osmotic delivery systems and piston assemblies for use therein |
US7989442B2 (en) | 2006-09-27 | 2011-08-02 | N.V. Organon | Progesterone receptor modulators |
JP5351884B2 (ja) | 2007-04-23 | 2013-11-27 | インターシア セラピューティクス,インコーポレイティド | インスリン分泌促進性ペプチドの懸濁製剤及び使用 |
US8063037B2 (en) | 2007-05-07 | 2011-11-22 | N. V. Organon | Progesterone receptor modulators |
TW200930343A (en) | 2007-09-21 | 2009-07-16 | Organon Nv | Drug delivery system |
EP2227252B1 (en) * | 2007-11-27 | 2012-07-25 | Nira Hochman | Adjuvant comprising vaccinium macrocarpon |
US8728528B2 (en) | 2007-12-20 | 2014-05-20 | Evonik Corporation | Process for preparing microparticles having a low residual solvent volume |
CA2726861C (en) | 2008-02-13 | 2014-05-27 | Intarcia Therapeutics, Inc. | Devices, formulations, and methods for delivery of multiple beneficial agents |
HUE035862T2 (en) | 2009-09-28 | 2018-05-28 | Intarcia Therapeutics Inc | Rapid development and / or completion of substantially steady-state drug delivery |
CA2785468A1 (en) * | 2009-12-23 | 2011-06-30 | Psivida Us, Inc. | Sustained release delivery devices |
US20120208755A1 (en) | 2011-02-16 | 2012-08-16 | Intarcia Therapeutics, Inc. | Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers |
US10028858B2 (en) | 2011-07-11 | 2018-07-24 | Medicines360 | Intrauterine systems, IUD insertion devices, and related methods and kits therefor |
AR089765A1 (es) * | 2012-01-23 | 2014-09-17 | Bayer Oy | Un sistema para el suministro de un farmaco |
US10154856B2 (en) | 2013-02-06 | 2018-12-18 | Mark SILLENDER | Therapeutic substance transfer catheter and method |
AU2014214538B2 (en) | 2013-02-06 | 2018-11-15 | Mark SILLENDER | Embryo transfer catheter and method |
US10413504B2 (en) | 2013-12-11 | 2019-09-17 | Merck Sharp & Dohme Corp. | Intravaginal ring drug delivery system |
US10596103B2 (en) | 2013-12-11 | 2020-03-24 | Merek Sharp & Dohme B.V. | Drug delivery system for delivery of anti-virals |
US9889085B1 (en) | 2014-09-30 | 2018-02-13 | Intarcia Therapeutics, Inc. | Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c |
WO2016149561A1 (en) * | 2015-03-17 | 2016-09-22 | Oak Crest Institute Of Science | Subdermal implants for the sustained delivery of water-soluble drugs |
ES2968262T3 (es) | 2015-06-03 | 2024-05-08 | I2O Therapeutics Inc | Sistemas de colocación de implantes |
WO2017200943A1 (en) | 2016-05-16 | 2017-11-23 | Intarcia Therapeutics, Inc. | Glucagon-receptor selective polypeptides and methods of use thereof |
USD860451S1 (en) | 2016-06-02 | 2019-09-17 | Intarcia Therapeutics, Inc. | Implant removal tool |
USD840030S1 (en) | 2016-06-02 | 2019-02-05 | Intarcia Therapeutics, Inc. | Implant placement guide |
WO2018064544A1 (en) | 2016-09-29 | 2018-04-05 | Gesea Biosciences Inc. | Bioerodible contraceptive implant and methods of use thereof |
CN110225762A (zh) | 2017-01-03 | 2019-09-10 | 因塔西亚制药公司 | 包括glp-1受体激动剂的连续施用和药物的共同施用的方法 |
US11571328B2 (en) | 2018-04-09 | 2023-02-07 | Medicines360 | IUD insertion devices |
WO2019226516A1 (en) | 2018-05-24 | 2019-11-28 | Celanese EVA Performance Polymers Corporation | Implantable device for sustained release of a macromolecular drug compound |
JP2021524840A (ja) * | 2018-05-24 | 2021-09-16 | セラニーズ・イーブイエイ・パフォーマンス・ポリマーズ・エルエルシー | 高分子薬剤化合物の持続放出用の埋め込み型デバイス |
US20200261258A1 (en) | 2019-02-19 | 2020-08-20 | Medicines360 | Devices, systems, methods and kits for insertion and removal of iuds |
BR102020007749A2 (pt) | 2020-04-17 | 2021-11-03 | Edson Luiz Peracchi | Implante subcutâneo reabsorvível de longa duração com liberação controlada de substância farmacologicamente ativa pré-concentrada em polímero para tratamento da endometriose |
BR102020010923A2 (pt) | 2020-05-29 | 2021-12-14 | Luiz Peracchi Edson | Implante subcutâneo reabsorvível de longa duração com liberação prolongada de substância farmacologicamente ativa pré-concentrada em polímero para tratamento da insuficiência adrenal crônica ou hipocortisolismo |
BR102020013862A2 (pt) | 2020-07-07 | 2022-01-18 | Edson Luiz Peracchi | Implante subcutâneo reabsorvível de longa duração com liberação sustentada de substância farmacologicamente ativa pré-concentrada em polímero para tratamento da doença de parkinson |
WO2022204771A1 (pt) | 2021-03-29 | 2022-10-06 | Edson Luiz Peracchi | Implante subcutâneo reabsorvível de longa duração com liberação prolongada de substância farmacologicamente ativa pré-concentrada em polímero para tratamento do hipotireoidismo e processo |
GB202401392D0 (en) | 2024-02-02 | 2024-03-20 | Imphatec Ltd | Implant for delivery of a drug |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3903880A (en) * | 1972-08-17 | 1975-09-09 | Alza Corp | Intrauterine device for managing the reproductive process |
US3926188A (en) * | 1974-11-14 | 1975-12-16 | Alza Corp | Laminated drug dispenser |
US4582052A (en) * | 1982-03-23 | 1986-04-15 | Repromed, Inc. | Povidone-iodine dispensing fiber |
NZ200564A (en) * | 1982-05-10 | 1987-03-06 | Ahi Operations Ltd | Device for slowly releasing chemicals into body cavities of animals |
US4601714A (en) * | 1983-07-07 | 1986-07-22 | Burnhill Michael S | Vaginal device |
US4629621A (en) * | 1984-07-23 | 1986-12-16 | Zetachron, Inc. | Erodible matrix for sustained release bioactive composition |
US4596576A (en) * | 1984-10-12 | 1986-06-24 | Akzo N.V. | Release system for two or more active substances |
US4720384A (en) * | 1985-05-03 | 1988-01-19 | E. I. Du Pont De Nemours And Company | Manufacture of hollow fine tubular drug delivery systems |
US4673565A (en) * | 1985-05-03 | 1987-06-16 | E. I. Du Pont De Nemours And Company | Pharmaceutical compositions containing hollow fine tubular drug delivery systems |
-
1988
- 1988-07-07 AT AT88201432T patent/ATE86484T1/de not_active IP Right Cessation
- 1988-07-07 DE DE8888201432T patent/DE3879031T2/de not_active Expired - Lifetime
- 1988-07-07 DE DE1999175054 patent/DE19975054I2/de active Active
- 1988-07-07 EP EP88201432A patent/EP0303306B1/en not_active Expired - Lifetime
- 1988-07-07 ES ES88201432T patent/ES2054784T3/es not_active Expired - Lifetime
- 1988-07-11 IE IE211888A patent/IE61730B1/en not_active IP Right Cessation
- 1988-07-12 ZA ZA885034A patent/ZA885034B/xx unknown
- 1988-07-13 NZ NZ225399A patent/NZ225399A/xx unknown
- 1988-07-25 CA CA000572897A patent/CA1309949C/en not_active Expired - Lifetime
- 1988-08-01 FI FI883594A patent/FI93421C/fi not_active IP Right Cessation
- 1988-08-04 AU AU20449/88A patent/AU603475B2/en not_active Expired
- 1988-08-05 US US07/229,066 patent/US4957119A/en not_active Expired - Lifetime
- 1988-08-05 DK DK198804386A patent/DK173166B1/da active Protection Beyond IP Right Term
- 1988-08-06 KR KR88010063A patent/KR950008763B1/ko not_active IP Right Cessation
- 1988-08-06 CN CN88104894A patent/CN1024753C/zh not_active Expired - Lifetime
- 1988-08-08 JP JP63197812A patent/JP2571831B2/ja not_active Expired - Lifetime
- 1988-08-08 PT PT88220A patent/PT88220B/pt not_active IP Right Cessation
-
1990
- 1990-06-21 US US07/541,559 patent/US5088505A/en not_active Expired - Lifetime
-
1992
- 1992-02-14 US US07/836,632 patent/US5150718A/en not_active Expired - Lifetime
- 1992-06-29 MX MX9203817A patent/MX9203817A/es unknown
-
1998
- 1998-02-11 HK HK98101032A patent/HK1002020A1/xx not_active IP Right Cessation
- 1998-09-30 NL NL980027C patent/NL980027I2/nl unknown
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1088993C (zh) * | 1996-10-11 | 2002-08-14 | 上海市计划生育科学研究所 | 含孕二烯酮的长效皮下避孕埋植剂 |
CN101209238B (zh) * | 2006-12-27 | 2012-05-09 | 辽宁省计划生育科学研究院 | 含孕二烯酮的生物降解型长效皮下避孕埋植剂及其制备 |
CN101130057B (zh) * | 2007-07-06 | 2011-04-27 | 复旦大学 | 胸腺五肽长效植入剂及其制备方法 |
CN113209050A (zh) * | 2021-05-14 | 2021-08-06 | 浙江恒冀制药有限责任公司 | 基于生物相容性聚合物的长效体内皮埋或内植缓释制剂 |
Also Published As
Publication number | Publication date |
---|---|
DE3879031D1 (de) | 1993-04-15 |
AU603475B2 (en) | 1990-11-15 |
PT88220B (pt) | 1995-03-01 |
IE882118L (en) | 1989-02-08 |
FI883594A (fi) | 1989-02-09 |
KR950008763B1 (en) | 1995-08-08 |
ATE86484T1 (de) | 1993-03-15 |
KR890003360A (ko) | 1989-04-14 |
DE3879031T2 (de) | 1993-06-24 |
NL980027I1 (nl) | 1998-12-01 |
IE61730B1 (en) | 1994-11-30 |
EP0303306B1 (en) | 1993-03-10 |
DK438688D0 (da) | 1988-08-05 |
US5150718A (en) | 1992-09-29 |
NL980027I2 (nl) | 1999-02-01 |
DK438688A (da) | 1989-02-09 |
FI93421C (fi) | 1995-04-10 |
PT88220A (pt) | 1989-06-30 |
DK173166B1 (da) | 2000-02-28 |
FI883594A0 (fi) | 1988-08-01 |
HK1002020A1 (en) | 1998-07-24 |
JPS6470410A (en) | 1989-03-15 |
ZA885034B (en) | 1989-03-29 |
JP2571831B2 (ja) | 1997-01-16 |
CN1024753C (zh) | 1994-06-01 |
MX9203817A (es) | 1992-08-01 |
FI93421B (fi) | 1994-12-30 |
US4957119A (en) | 1990-09-18 |
ES2054784T3 (es) | 1994-08-16 |
AU2044988A (en) | 1989-03-02 |
DE19975054I2 (de) | 2000-04-13 |
NZ225399A (en) | 1990-09-26 |
EP0303306A1 (en) | 1989-02-15 |
CA1309949C (en) | 1992-11-10 |
US5088505A (en) | 1992-02-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1024753C (zh) | 避孕植入剂的制造方法 | |
CN1066966C (zh) | 低熔和/或挥发性活性物膏药 | |
CN1296516A (zh) | 烯化氧聚合物组合物 | |
CN1049787A (zh) | 胃逗留装置 | |
CN1048712A (zh) | 含有无序结构淀粉的以聚合物为基料的混合组合物 | |
CN1062290A (zh) | 低雌激素的口服避孕药 | |
CN1268879A (zh) | 基于胶原蛋白的生物相容性的能吸收紫外线的光学透明的聚合材料及其制造方法 | |
CN1007729B (zh) | 吸水树脂组合物 | |
CN1233945A (zh) | 造口术器具 | |
CN101036633A (zh) | 一种奥美拉唑肠溶微丸胶囊及其制备方法 | |
CN1127529A (zh) | 人白细胞介素-10的激动剂和拮抗剂 | |
CN1809643A (zh) | 在膜蛋白中插入弗林蛋白酶切割位点及其用途 | |
CN1896107A (zh) | 类天蚕素a-马盖宁杂合基因工程抗菌肽 | |
CN1280489A (zh) | 栓剂组合物 | |
CN1840177A (zh) | 胸腺肽α1注射液及其制备方法 | |
CN1265798C (zh) | 含有藻酸盐的药物组合物 | |
CN1589133A (zh) | 不透射线的缓释药物系统 | |
CN101036784A (zh) | 一种乙型肝炎治疗性细胞毒性t细胞表位疫苗及其制备方法 | |
CN1764371A (zh) | 遗体体液防漏装置 | |
CN1045228A (zh) | 一种能有效地延长防止、治疗或控制线虫、蜱螨类和内外寄生虫对反刍动物侵染,并能持久释放的大丸药 | |
CN1638747A (zh) | 持续释放药物组合物 | |
CN1879605A (zh) | 一种微乳型人工泪液 | |
CN1184960C (zh) | 多颗粒药剂、构成它的颗粒、制备它的方法和装置 | |
CN1899287A (zh) | 一种治疗焦虑症的缓释药物组合物及其制备方法 | |
CN1208057C (zh) | 复方莪术油制剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C15 | Extension of patent right duration from 15 to 20 years for appl. with date before 31.12.1992 and still valid on 11.12.2001 (patent law change 1993) | ||
OR01 | Other related matters | ||
ASS | Succession or assignment of patent right |
Owner name: ORGANON NV Free format text: FORMER OWNER: AKZO NOVEL N.V. CORP. Effective date: 20070309 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C56 | Change in the name or address of the patentee |
Owner name: AKZO NOVEL N.V. CORP. Free format text: FORMER NAME OR ADDRESS: AKZO N. V. |
|
CP03 | Change of name, title or address |
Address after: Holland Arnhem Patentee after: AKZO NOBEL N.V. Address before: Holland Arnhem Patentee before: Akzo N |
|
TR01 | Transfer of patent right |
Effective date of registration: 20070309 Address after: Holland Patentee after: N.V. ORGANON Address before: Holland Arnhem Patentee before: AKZO NOBEL N.V. |
|
C17 | Cessation of patent right | ||
CX01 | Expiry of patent term |